Literature DB >> 3629457

Magnetic resonance imaging: lumbosacral lipoma.

M Komiyama, A Hakuba, Y Inoue, T Yasui, H Yagura, M Baba, S Nishimura.   

Abstract

To evaluate the clinical efficacy of magnetic resonance imaging (MRI) of lumbosacral lipomas, the magnetic resonance images of nine patients were reviewed. T1- and T2-weighted spin echo sequences were used with a 0.5-T magnetic resonance system. The tethered or low-positioned conus medullaris, the lipoma itself, the lipoma--cord interface, the subarachnoid space, and hydromyelia were clearly disclosed. The nerve rootlets were not as clear. These results indicate the possible discontinuance of myelography and metrizamide computed tomography (CT) cisternography for such imaging. The diagnostic modalities of choice for lumbosacral lipoma imaging are plain spine films, plain CT scan, and MRI.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3629457     DOI: 10.1016/0090-3019(87)90303-x

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  5 in total

1.  Thickened fatty filum terminale: MR imaging.

Authors:  A Uchino; T Mori; M Ohno
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

Review 2.  Intramedullary spinal tumors of disordered embryogenesis.

Authors:  K Muraszko; A Youkilis
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

3.  Pre- and post-operative hydromyelia in spinal dysraphism.

Authors:  James H Scatliff; Richard Hayward; Diane Armao; Lanna Kwon
Journal:  Pediatr Radiol       Date:  2004-10-15

4.  MRI study of lumbosacral lipoma in children.

Authors:  V Taviere; F Brunelle; J Baraton; M Temam; A Pierre-Kahn; D Lallemand
Journal:  Pediatr Radiol       Date:  1989

5.  Whole spine MRI is not required in investigating uncomplicated paediatric lumbosacral lipoma. A retrospective single-institution review.

Authors:  Hugo Layard Horsfall; Aswin Chari; Terhi Huttunen; Clare Simcock; Felice D'Arco; Dominic Thompson
Journal:  Childs Nerv Syst       Date:  2019-09-09       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.